Galecto Inc. (GLTO) NASDAQ
$0.78 - (-)
Market Cap: $21.15M
As of 03/28/24 04:00 PM EDT. Market closed.
Galecto Inc. (GLTO)
NASDAQ
$0.78
- (-)
Market Cap: $21.15M
As of 03/28/24 04:00 PM EDT. Market closed.
galecto biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. the company’s products target galectins, a group of proteins that play important roles in many disorders. galecto biotech’s high potency galectin modulators may open new treatment possibilities for many patients. the company, which is ... read more
galecto biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. the company’s products target galectins, a group of proteins that play important roles in many disorders. galecto biotech’s high potency galectin modulators may open new treatment possibilities for many patients. the company, which is located in lund, sweden, is led by top-level scientists and biotech executives. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
ORBIMED ADVISORS LLC | 10% Owner | Aug 15, 2023 | Sale | $0.75 | 822,680 | 617,010 | 1,510,375 | Aug 17, 2023, 04:40 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jul 31, 2023 | Sale | $3.00 | 209,400 | 628,200 | 2,105,909 | Aug 02, 2023, 05:05 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jul 25, 2023 | Sale | $2.92 | 39,200 | 114,464 | 2,258,987 | Jul 27, 2023, 04:28 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jul 13, 2023 | Sale | $2.40 | 194,700 | 467,280 | 2,285,687 | Jul 17, 2023, 04:13 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 17, 2023 | Sale | $1.97 | 13,089 | 25,785 | 2,417,787 | Apr 17, 2023, 05:28 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 14, 2023 | Sale | $1.86 | 41,446 | 77,090 | 2,426,665 | Apr 17, 2023, 05:28 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 13, 2023 | Sale | $1.82 | 13,946 | 25,382 | 2,454,775 | Apr 17, 2023, 05:28 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 12, 2023 | Sale | $1.81 | 2,363 | 4,277 | 2,464,234 | Apr 12, 2023, 06:44 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 11, 2023 | Sale | $1.82 | 13,946 | 25,382 | 2,465,837 | Apr 12, 2023, 06:44 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 10, 2023 | Sale | $1.79 | 51,228 | 91,698 | 2,500,582 | Apr 12, 2023, 06:44 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 06, 2023 | Sale | $2.00 | 9,665 | 19,330 | 2,510,041 | Apr 07, 2023, 04:42 PM |
ORBIMED ADVISORS LLC | 10% Owner | Apr 05, 2023 | Sale | $2.18 | 92,965 | 202,664 | 2,516,599 | Apr 07, 2023, 04:42 PM |
Lindmark Bertil | Chief Medical Officer | Mar 22, 2022 | Buy | $2.16 | 14,604 | 31,545 | 16,604 | Mar 23, 2022, 08:00 AM |
Schambye Hans T. | Chief Executive Officer | Mar 22, 2022 | Buy | $2.15 | 5,000 | 10,750 | 52,428 | Mar 23, 2022, 08:00 AM |
Winslow Garrett | General Counsel | Dec 03, 2021 | Buy | $2.48 | 2,000 | 4,960 | 4,000 | Dec 06, 2021, 08:00 AM |
Freve Jonathan | Chief Financial Officer | Dec 03, 2021 | Buy | $2.49 | 4,000 | 9,960 | 12,000 | Dec 06, 2021, 08:00 AM |
Schambye Hans T. | Chief Executive Officer | Nov 09, 2021 | Buy | $3.50 | 4,500 | 15,750 | 47,428 | Nov 10, 2021, 08:00 AM |
Freve Jonathan | Chief Financial Officer | Nov 08, 2021 | Buy | $3.40 | 3,000 | 10,200 | 8,000 | Nov 09, 2021, 08:00 AM |
Freve Jonathan | Chief Financial Officer | Aug 18, 2021 | Buy | $3.92 | 3,000 | 11,760 | 5,000 | Aug 19, 2021, 04:00 PM |
Lindmark Bertil | Chief Medical Officer | Jun 28, 2021 | Buy | $5.26 | 2,000 | 10,520 | 2,000 | Jun 28, 2021, 04:00 PM |
Schambye Hans T. | Chief Executive Officer | Jun 24, 2021 | Buy | $5.11 | 3,000 | 15,330 | 42,928 | Jun 24, 2021, 04:00 PM |
Freve Jonathan | Chief Financial Officer | Jun 23, 2021 | Buy | $4.74 | 2,000 | 9,480 | 2,000 | Jun 23, 2021, 04:00 PM |
Winslow Garrett | General Counsel | Jun 23, 2021 | Buy | $4.80 | 2,000 | 9,600 | 2,000 | Jun 23, 2021, 04:00 PM |
ORBIMED ADVISORS LLC | Director | Nov 02, 2020 | Buy | $15.00 | 733,333 | 10,999,995 | 2,579,657 | Nov 04, 2020, 08:00 PM |
Khuong Chau Quang | Director | Nov 02, 2020 | Buy | $15.00 | 733,333 | 10,999,995 | 2,579,657 | Nov 04, 2020, 08:00 PM |
Christgau Stephan | Director | Nov 02, 2020 | Buy | $15.00 | 66,666 | 999,990 | 546,136 | Nov 04, 2020, 08:00 PM |
Novo Holdings A/S | 10% Owner | Nov 02, 2020 | Buy | $15.00 | 333,333 | 4,999,995 | 2,497,791 | Nov 04, 2020, 07:52 PM |
Owner | Relationship | Date | Value($) |
ORBIMED ADVISORS LLC | 10% Owner | 08/15/2023 | 617,010 |
ORBIMED ADVISORS LLC | 10% Owner | 07/31/2023 | 628,200 |
ORBIMED ADVISORS LLC | 10% Owner | 07/25/2023 | 114,464 |
ORBIMED ADVISORS LLC | 10% Owner | 07/13/2023 | 467,280 |
ORBIMED ADVISORS LLC | 10% Owner | 04/17/2023 | 25,785 |
ORBIMED ADVISORS LLC | 10% Owner | 04/14/2023 | 77,090 |
ORBIMED ADVISORS LLC | 10% Owner | 04/13/2023 | 25,382 |
ORBIMED ADVISORS LLC | 10% Owner | 04/12/2023 | 4,277 |
ORBIMED ADVISORS LLC | 10% Owner | 04/11/2023 | 25,382 |
ORBIMED ADVISORS LLC | 10% Owner | 04/10/2023 | 91,698 |
ORBIMED ADVISORS LLC | 10% Owner | 04/06/2023 | 19,330 |
ORBIMED ADVISORS LLC | 10% Owner | 04/05/2023 | 202,664 |
Lindmark Bertil | Chief Medical Officer | 03/22/2022 | 31,545 |
Schambye Hans T. | Chief Executive Officer | 03/22/2022 | 10,750 |
Winslow Garrett | General Counsel | 12/03/2021 | 4,960 |
Freve Jonathan | Chief Financial Officer | 12/03/2021 | 9,960 |
Schambye Hans T. | Chief Executive Officer | 11/09/2021 | 15,750 |
Freve Jonathan | Chief Financial Officer | 11/08/2021 | 10,200 |
Freve Jonathan | Chief Financial Officer | 08/18/2021 | 11,760 |
Lindmark Bertil | Chief Medical Officer | 06/28/2021 | 10,520 |
Schambye Hans T. | Chief Executive Officer | 06/24/2021 | 15,330 |
Freve Jonathan | Chief Financial Officer | 06/23/2021 | 9,480 |
Winslow Garrett | General Counsel | 06/23/2021 | 9,600 |
ORBIMED ADVISORS LLC | Director | 11/02/2020 | 10,999,995 |
Khuong Chau Quang | Director | 11/02/2020 | 10,999,995 |
Christgau Stephan | Director | 11/02/2020 | 999,990 |
Novo Holdings A/S | 10% Owner | 11/02/2020 | 4,999,995 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 924,788 | 0.01% | Exited | Other |
RENAISSANCE TECHNOLOGIES LLC | 406,968 | 0.00045% | 98.42% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 208,333 | 0.00002% | No change | Other |
BLACKROCK INC. | 52,106 | 0% | -0.9% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View